LetterAdministering multiple cumulative allergen challenges: An alternative nasal allergen challenge protocol for the Allergic Rhinitis–Clinical Investigator Collaborative
References (10)
- et al.
Nasal allergen challenge studies of allergic rhinitis: a guide for the practicing clinician
Ann Allergy Asthma Immunol
(2014) - et al.
Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes
J Immunol Methods
(2012) - et al.
Influences of nasal lavage collection-, processing- and storage methods on inflammatory markers: evaluation of a method for non-invasive sampling of epithelial lining fluid in cystic fibrosis and other respiratory diseases
J Immunol Methods
(2014) - et al.
The Nasal Allergen Challenge Protocol of the Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): Validation in a Clinical Trial of Cat Synthetic Peptide Immunoregulatory Epitopes (Cat-SPIRE)
J Allergy Clin Immunol
(2015) - et al.
The Allergic Rhinitis – Clinical Investigator Collaborative (AR-CIC): nasal allergen challenge protocol optimization for studying AR pathophysiology and evaluating novel therapies
Allergy Asthma Clin Immunol
(2015)
Cited by (0)
Disclosures: In the past 12 months, Dr Ellis has participated in advisory boards for Circassia Ltd, GSK, Merck, and Novartis; she has been a speaker for Novartis, Merck, Pfizer, Takeda, and AstraZeneca; and her institution received research grants from GSK, Circassia Ltd, SunPharma, Merck, Pfizer, and Novartis. Dr Ellis is also a consultant to Ora Inc and ALK-Abello, Canada. Dr Neighbour has received support from GSK and Adiga Lifesciences and has served on the speaker's bureau and received honoraria from Merck, Astra-Zeneca, GSK, and Novartis. No other disclosures were reported.
Funding Sources: This study was supported by the AllerGen Network Centre of Excellence, Project #12CIC-AR, and the William M. Spear Endowment Fund/Start Memorial Fund.